Biotest Aktiengesellschaft (BIO3) — Long-term Investment Intensity
Biotest Aktiengesellschaft (BIO3) has a Long-term Investment Intensity of 1.1% as of September 2019. Long-term investments of €11.90 Million represent 1.1% of total assets of €1.09 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Biotest Aktiengesellschaft (BIO3) shareholders funds for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Biotest Aktiengesellschaft Long-term Investment Intensity (2013–2018)
This chart shows how Biotest Aktiengesellschaft's Long-term Investment Intensity has evolved across 6 annual periods from 2013 to 2018. As of September 2019, the intensity stands at 1.1%, reflecting long-term investments of €11.90 Million against total assets of €1.09 Billion EUR. Also explore Biotest Aktiengesellschaft total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Biotest Aktiengesellschaft (2013–2018)
The table below presents the year-by-year Long-term Investment Intensity for Biotest Aktiengesellschaft from 2013 to 2018, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Biotest Aktiengesellschaft.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.2% | €1.90 Million | €1.04 Billion | ▼ -0.1 pp |
| 2017 | 0.2% | €2.30 Million | €978.50 Million | ▼ -0.2 pp |
| 2016 | 0.5% | €4.30 Million | €932.80 Million | ▲ +0.1 pp |
| 2015 | 0.4% | €3.50 Million | €962.70 Million | ▲ +0.2 pp |
| 2014 | 0.1% | €1.50 Million | €1.03 Billion | ▼ -0.1 pp |
| 2013 | 0.2% | €1.80 Million | €886.50 Million | — |